Primary Sjögren's Syndrome

N Engl J Med. 2018 Mar 8;378(10):931-939. doi: 10.1056/NEJMcp1702514.

Authors

Xavier Mariette¹, Lindsey A Criswell¹

Affiliation

¹ From the Department of Rheumatology, Université Paris Sud, INSERM Unité 1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris Sud, Le Kremlin Bicêtre, France (X.M.); and the Rosalind Russell-Ephraim P. Engleman Rheumatology Research Center, Departments of Medicine and Orofacial Sciences, University of California at San Francisco, San Francisco (L.A.C.).

PMID: 29514034
DOI: 10.1056/NEJMcp1702514

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Analgesics / therapeutic use
Antibodies, Antinuclear / blood
Female
Humans
Immunologic Factors / therapeutic use*
Middle Aged
Muscarinic Agonists / therapeutic use
Parotid Gland / diagnostic imaging
Rituximab / therapeutic use*
Sjogren's Syndrome* / complications
Sjogren's Syndrome* / diagnosis
Sjogren's Syndrome* / drug therapy
Ultrasonography

Substances

Analgesics
Antibodies, Antinuclear
Immunologic Factors
Muscarinic Agonists
Rituximab